Faculty
- Michel Goldman (ULB)
- Bruno van Lierde (ULB)
- Hilde Stevens (ULB)
- Bruno Flamion (University of Namur)
- Magda Rosenmöller (IESE, Barcelona)
- Jean-Louis Vincent (ULB)
- Julie Gaye (ULB)
- Gauthier Bouche (Anti-Kankerfonds)
- Sir Alasdair Breckenridge (Former Chair of the UK’s Medicines and Healthcare Products Regulatory Agency)
- Mattias Neyt (Belgian Health Care Knowledge Centre (KCE) and ME-TA)
- Alain Delchambre (ULB)
- Jacques Deviere (ULB)
- Magda Papadaki, (Association of the British Pharmaceutical Industry)
- Mariana Igoillo (ULB)
- Marie Neunez (ULB)
- Lode Dewulf (Doctors of the World)
- Mitchell Silva (Esperity, ReumaNet, EUPATI BE)
- Dipak Kalra (European Institute for Health Records and University College of London)
- Hugues Bersini (ULB)
- Isabelle Huys (KU Leuven)
- Ingrid Klingmann (PharmaTrain Federation)
- Françoise Meunier (EORTC)
- Patrick Legros (ULB)
- Bill Hausdorff (ULB)
- Michel Katzatchkine (UN Special Envoy on HIV/AIDS)
- Olivier Vandenberg (ULB)
- Samia Laokri (ULB)
- Elke Giets (IMEC)
- Thomas Van der Auwermeulen (IMEC, PRIDIKTIV)
- Olivier Witmeur (ULB)
- Denise Bjorkman (Liv, US)
- Dimitrios Tzalis (Taros GmbH)
- John Metselaar (J-Met Connect)
- Patrick Crasson (BeNovate)
- Philippe Monteyne (Fund+)
- Alain Parthoens (Vesalius Biocapital)